Skip to main content
Premium Trial:

Request an Annual Quote

Kreatech to Use GE Healthcare s Labeling Technology in Microarray Kits

NEW YORK, Feb. 22 (GenomeWeb News) - Kreatech Biotechnology said yesterday that it has signed an agreement allowing it to use GE Healthcare's Universal Linkage System and fluorescent dye technology in DNA microarray-labeling kits.

 

Under the terms of the agreement, Kreatech gains global rights for the use of Cy3 and Cy5 dyes with the Universal Linkage System in fluorescent applications within the life sciences market, Kreatech said. Kreatech will use the technology to develop and manufacture microarray-labeling kits for amplified RNA labeling and genomic DNA labeling, it said.

 

Kreatech said the technology enables direct DNA labeling, negating the need for modified nucleotides.

 

Financial terms of the deal were not disclosed.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.